Cardio-Renal-Metabolic (CaReMeUK) have recently produced an algorithm on 'Cardiovascular risk optimisation in type 2 diabetes and atherosclerotic cardiovascular disease'.
To view this algorithm in full and information about the guideline that this was taken from, please click here.
